---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-027295"
form_type: "8-K/A"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2022-09-30T23:59:59+00:00"
generated_at: "2026-06-23T06:34:17.270331+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Lineage Cell corrects CEO salary to $609k in amended employment agreements

## Summary
- Corrects CEO Brian Culley's base annual salary from $690,000 to $609,000.
- Corrects cash severance payment method: installments for termination without cause/good reason, lump sum only within change-of-control window.
- Other terms unchanged: Samuel salary $394,800, Hogge $366,800; bonus targets 55%, 40%, 35% respectively.
- Board adopted Executive Performance Incentive Bonus Plan (as originally disclosed).

## SEC filing metadata
- accession: 0001493152-22-027295
- form_type: 8-K/A
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2022-09-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000149315222027295/0001493152-22-027295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000149315222027295/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-027295
- JSON: https://secwatch.observer/filing/0001493152-22-027295.json
- Plain text: https://secwatch.observer/filing/0001493152-22-027295.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.